Zivo Bioscience Inc. (ZIVO)
NASDAQ (CM) NASDAQ (CM) Primary Summary
Zivo Bioscience Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| CAL CoreCap Advisors LLC CoreCap Advisors LLC | 4,360 | $65,007.6 | $14,736.8 | -$50,270.8 | -77.33% |
Zivo Bioscience Inc. (ZIVO) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Zivo Bioscience Inc. ever had a stock split?
Zivo Bioscience Inc. Profile
| Biotechnology Industry | Healthcare Sector | John Bernard Payne CEO | NASDAQ (CM) Exchange | 98978N200 CUSIP |
| US Country | 7 Employees | - Last Dividend | 27 Oct 2023 Last Split | 24 Sep 2012 IPO Date |
Overview
ZIVO Bioscience, Inc. is a dynamic company positioned at the intersection of biotechnology and agricultural technology, specializing in the research and development of natural bioactive compounds derived from its proprietary algae cultures. The company, originally known as Health Enhancement Products, Inc., underwent a rebranding to ZIVO Bioscience, Inc. in October 2014, signifying a strategic pivot towards leveraging its cutting-edge algal research for various applications. ZIVO Bioscience focuses on licensing and selling its novel ingredients to a wide range of manufacturers in the animal health, human nutrition, dietary supplements, and medical food sectors. With its headquarters in Bloomfield Hills, Michigan, the company boasts a robust intellectual property portfolio that includes unique algal and bacterial strains, bioactive molecules, advanced production and cultivation techniques, and a range of patented or patent-pending inventions aimed at addressing the health needs of humans and animals alike.
Products and Services
ZIVO Bioscience’s product offerings are diversified across a spectrum of health and nutritional applications, each uniquely designed to harness the inherent benefits of its proprietary algal cultures. Below is a detailed overview of their key products and services:
- Poultry Gut Health: The company has developed bioactive ingredients aimed at enhancing gut health in poultry. These natural additives are designed to support the digestive functionality and overall well-being of poultry, potentially reducing the need for antibiotics.
- Bovine Mastitis: ZIVO offers solutions targeting bovine mastitis, a significant health issue in dairy cows affecting milk production and quality. Their natural compounds aim to provide a safer, bio-based approach to managing this condition, thereby improving dairy herd health and productivity.
- Canine Joint Health: Recognizing the common issue of joint health in dogs, ZIVO Bioscience has synthesized ingredients focused on supporting canine mobility and joint health. This natural supplement option offers a beneficial alternative for pet owners seeking to maintain their pets' health and activity levels.
- Human Immune Modification: Leveraging its advanced research in bioactive compounds, the company is engaged in developing products designed to modulate and support the human immune system. These nature-inspired solutions aim to contribute to better health outcomes and enhanced immune responsiveness.
- Algal Biomass for Human Consumption: ZIVO Bioscience capitalizes on its expertise in algal cultivation by producing high-quality biomass that is suitable for direct human consumption. This nutritious product is intended to serve as a supplemental source of natural nutrients and bioactive compounds.
- Biomass for Supporting Skin Health / Anti-Aging: The company also focuses on the application of its algal biomass in the skincare and anti-aging sector. By offering compounds that assist in maintaining skin health and potentially mitigating aging signs, ZIVO aims to contribute to the burgeoning demand for natural skincare solutions.
